Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
about
Redox activation of metal-based prodrugs as a strategy for drug deliveryDevelopment and exploration of a new methodology for the fitting and analysis of XAS data.The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro.Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse.X-ray absorption near edge structure spectroscopy to resolve the in vivo chemistry of the redox-active indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019).
P2860
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@ast
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@en
type
label
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@ast
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@en
prefLabel
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@ast
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@en
P2860
P1476
Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
@en
P2093
Karen L McFarlane Holman
Travis V Harris
P2860
P2888
P304
P356
10.1007/S00775-009-0501-0
P577
2009-04-07T00:00:00Z